Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on ATAI Life Sciences (ATAI – Research Report). The associated ...

Atai Life Sciences (NASDAQ:ATAI) reported positive topline results from a Phase 2a study of the psychedelic drug BPL-003 in the treatment of patients with moderate to severe alcohol use disorder, or ...

Healthcare and vaccine stocks are likely to be in the spotlight on Wednesday as Robert F. Kennedy Jr., U.S. President Donald Trump's pick to run the Department of Health and Human Services, is due to ...

Operatives of the Akwa Ibom State Police Command have arrested one Christiana Ibanga and her boyfriend, Inyene Akpan, over ...

Operatives of the Akwa Ibom State Police Command have arrested a lady, Christiana Ibanga, and her boyfriend, Inyene Akpan, ...

ATAI Life Sciences N.V. (NASDAQ:ATAI), a pharmaceutical company specializing in the development of treatments for mental health conditions with a market capitalization of $263 million, announced the ...

Operatives of the Akwa Ibom State Police Command have arrested a lady, Christiana Ibanga, and her boyfriend, Inyene Akpan, for allegedly trafficking their own child and selling the infant for ₦450,000 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...